Eltrombopag Added to Standard Immunosuppression for Aplastic Anemia

BACKGROUND: Acquired aplastic anemia results from immune-mediated destruction of bone marrow. Immunosuppressive therapies are effective, but reduced numbers of residual stem cells may limit their efficacy. In patients with aplastic anemia that was refractory to immunosuppression, eltrombopag, a synt...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:N Engl J Med
Main Authors: Townsley, Danielle M., Scheinberg, Phillip, Winkler, Thomas, Desmond, Ronan, Dumitriu, Bogdan, Rios, Olga, Weinstein, Barbara, Valdez, Janet, Lotter, Jennifer, Feng, Xingmin, Desierto, Marie, Leuva, Harshraj, Bevans, Margaret, Wu, Colin, Larochelle, Andre, Calvo, Katherine R., Dunbar, Cynthia E., Young, Neal S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2017
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5548296/
https://ncbi.nlm.nih.gov/pubmed/28423296
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1613878
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados